603811 logo

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Stock Price

SHSE:603811 Community·CN¥3.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603811 Share Price Performance

CN¥7.60
0.38 (5.24%)
CN¥7.60
0.38 (5.24%)
Price CN¥7.60

603811 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

0 Risks
1 Reward

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Key Details

CN¥827.8m

Revenue

CN¥257.1m

Cost of Revenue

CN¥570.7m

Gross Profit

CN¥377.1m

Other Expenses

CN¥193.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 27, 2026
0.44
68.94%
23.39%
3.8%
View Full Analysis

About 603811

Founded
1966
Employees
604
CEO
Chunjian Zhao
WebsiteView website
www.chengyipharma.com

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

Recent 603811 News & Updates

Recent updates

No updates